Could pump therapy offer advantages over conventional insulin delivery during the peri-operative period?

Hammond, Peter
December 2013
Diabetes Digest;2013, Vol. 12 Issue 4, p186
The article presents a retrospective study which evaluates all the surgical procedures of individuals with diabetes in one centre in China over six years. The authors of the study examined the safety and efficacy of continuous subcutaneous insulin infusion (CSII) during the patients' peri-operative care. The CSII group had lower incidence of fever, lower fasting glucose and lower food glucose compared with the control group.


Related Articles

  • Insulin Pump Class: Back to the Basics of Pump Therapy. Reece, Sara Wilson; Hamby Williams, Cheryl Lynn // Diabetes Spectrum;Spring2014, Vol. 27 Issue 2, p135 

    The article offers information about the insulin pump. It is an electromechanical device which mimics the body's natural insulin secretion from pancreatic cells by delivering rapid-acting insulin. The insulin pumps consist of a reservoir, a pump and an infusion set. The education for insulin...

  • Sensor-augmented CSII improves HbA1C in people with poorly controlled T1D.  // Diabetes Digest;2012, Vol. 11 Issue 1, p18 

    The article focuses on the study by J. Hermanides and colleagues which shows that sensor-augmented continuous subcutaneous insulin infusion (CSII) therapy can reduce hemoglobin (Hb)A1c in patients with type 1 diabetes (T1D).

  • Continuous subcutaneous insulin infusion: The successful transfer of a pump service to a community diabetes team. Allen, Nicola; Choo-Kang, Alan; Shelley, Sharon; Taplin, Julie // Journal of Diabetes Nursing;2013, Vol. 17 Issue 10, p369 

    This article describes the transfer of a continuous subcutaneous insulin infusion (CSII) service from a small secondary care team to a larger community-based team. The changeover allowed people to be reassessed and re-educated on the use of their pump. It also allowed for more effective...

  • Racial Gap in Glycemic Control Eludes Explanation.  // Clinician Reviews;Jun2008, Vol. 18 Issue 6, p12 

    The article discusses a study on medication adherence and racial differences in glycated hemoglobin (A1C) control published in the 2008 issue of the periodical "Diabetes Care." The researchers explain that adherence to diabetes medications leads to clinically significant reductions in A1C levels...

  • Near Normalization of Metabolic Control in Type-1 DM Using Conventional Insulin Therapy (CIT) and a 13-Point Method Designed to Enhance Compliance. Guevara-Aguirre, Jaime; Guevara-Aguirre, Marco; Saavedra, Jeannette; Bernstein, Gerald // Diabetes;Jun2007 Supplement 1, Vol. 56, pA615 

    The article discusses a study on the normalization of metabolic control on type-1 DM using conventional insulin therapy (CIT) and a 13-point method that are designed to enhance compliance. The study measured the fructosamine and glycated hemoglobin in diabetic subjects every two weeks. The...

  • CSII therapy: 4-year efficacy and safety in children.  // Diabetes Digest;2012, Vol. 11 Issue 3, p157 

    The article discusses a study by S.R. Hughes and colleagues to evaluate the sustained benefits of continuous subcutaneous insulin infusion (CSII), which revealed that CSII therapy yields significant and sustained improvements in glycemic control in children.

  • Effects of Mobile Phone SMS to Improve Glycemic Control Among Patients With Type 2 Diabetes in Bangladesh: A Prospective, Parallel-Group, Randomized Controlled Trial. Sheikh Mohammed Shariful Islam; Niessen, Louis W.; Ferrari, Uta; Ali, Liaquat; Seissler, Jochen; Lechner, Andreas // Diabetes Care;Aug2015, Vol. 38 Issue 8, pe112 

    The article discusses a study which assessed whether the addition of an automated short message service (SMS) to standard diabetes care would improve glycemic control in type 2 diabetes patients. Topics covered include the self-reported adherence to medication in both the SMS and the control...

  • INSULIN PUMPS.  // Diabetes Health Professional;Dec2013/Jan2014, Vol. 22 Issue 6, p26 

    The article offers brief information on several insulin pumps including the OmniPod Insulin Management System from Insulet Corp., the OneTouch Ping Glucose Management System from Animas Corp. and the MiniMed 530G with Enlite from Medtronic.

  • Insulin pump therapy: impact on the lives of children/young people with diabetes mellitus and their parents. Alsaleh, Fatemah; Smith, Felicity; Thompson, Rebecca; Al-Saleh, Mohammad; Taylor, Kevin // International Journal of Clinical Pharmacy;Oct2014, Vol. 36 Issue 5, p1023 

    Background Advances in medical technology and research documenting clinical effectiveness have led to the increased use of insulin pumps worldwide. However, their use by children in the UK is relatively limited and there is little evidence regarding their impact on patients' lives. Objective...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics